Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/21/2012CN102382171A Polypeptide for inhibiting hepatitis C virus infected cell and application thereof
03/21/2012CN102382169A Argatroban single stereoisomer separation method and polymorph
03/21/2012CN102380100A Stable protease composition
03/21/2012CN102380099A Application of Wnt2 to preparation of medicament for inhibiting esophageal cancer
03/21/2012CN102380098A Combination therapy for the treatment of ocular neovascular disorders
03/21/2012CN102380091A Application of interleukin-22 in curing virus hepatitis
03/21/2012CN102380090A G-CSF (granulocyte-colony stimulating factor) dimmer applied to treat neutropenia
03/21/2012CN102380089A Novel application of intermedin 1-53 in preparing medicament for treating glucose metabolism disturbance
03/21/2012CN102380088A Prescription and preparation method of thymopeptide-5 injection
03/21/2012CN102379884A Inhibition of fatty acid synthesis by PARP inhibitors and methods of treatment thereof
03/21/2012CN101979090B Medicament for treating tumors
03/21/2012CN101812135B Fusion protein with high-efficient platelet-increasing role and preparation method thereof
03/21/2012CN101805738B Peculiar p53 mutated protein-p53N236S of ALT tumor caused by progeria syndrome and application thereof
03/21/2012CN101704886B Human alpha-defensin 5 antiviral active mutant polypeptide and preparation method and application
03/21/2012CN101591386B Polypeptide capable of inhibiting excitable and toxic damages and use thereof
03/21/2012CN101555283B Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
03/21/2012CN101457226B Gene with nerve repair function, coding protein, interactive receptor and use thereof
03/21/2012CN101381757B Solid fermentation preparation method of antibacterial peptide and application
03/21/2012CN101340893B Intranasal administration of rapid acting insulin
03/21/2012CN101277713B Composition for acceleration of type I collagen production
03/21/2012CN101177700B Methods and means for producing proteins with predetermined post-translational modifications
03/21/2012CN101168564B Human antibiotic peptide and use for derivative thereof
03/21/2012CN101164543B Acyl pseudopeptides bearing a functionalised auxiliary spacer
03/21/2012CN101085345B High mannose proteins and methods of making high mannose proteins
03/21/2012CA2752784A1 Daptomycin formulation
03/20/2012US8138328 Modulation of apolipoprotein (A) expression
03/20/2012US8138323 Cytokines; side effect reduction; bactericides; antitumor agents; anticarcinogenic agents
03/20/2012US8138312 Compositions for regulation of tumor necrosis factor-alpha
03/20/2012US8138311 Modified proteins, designer toxins, and methods of making thereof
03/20/2012US8138310 Chimeric CD154 polypeptides
03/20/2012US8138307 Parkin interacting polypeptides and methods of use
03/20/2012US8138306 Isolating preferential protein and/or peptides from liquid comprising uncharged ligand matrix;
03/20/2012US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease.
03/20/2012US8138304 Neural regeneration peptides and formulations thereof
03/20/2012US8138157 Antibiotic formulation and method of treatment
03/20/2012US8138156 Ophthalmic compositions containing diglycine
03/20/2012US8138155 Compounds for intracellular delivery of therapeutic moieties to nerve cells
03/20/2012US8138154 Biglycan and related therapeutics and methods of use
03/20/2012US8138153 Potassium channel modulator peptide
03/20/2012US8138152 Methods of treatment using WISP polypeptides
03/20/2012US8138151 Peptides
03/20/2012US8138150 Method for removing endotoxin from proteins
03/20/2012US8138149 Nasal calcitonin formulations containing chlorobutanol
03/20/2012US8138148 GDNF derived peptides
03/20/2012US8138147 Conditioned cell culture medium compositions and methods of use
03/20/2012US8138145 Hybrid oligomers, their preparation process and pharmaceutical compositions containing them
03/20/2012US8138144 Antimicrobial cationic peptides and formulations thereof
03/20/2012US8138143 Methods for treating a neurological disorder by peripheral administration of a trophic factor
03/20/2012US8138142 Methods for increasing adiponectin in a patient in need thereof
03/20/2012US8138141 HMG1 antibody for treating inflammatory conditions
03/20/2012US8138140 Self-assembling peptide amphiphiles and related methods for growth factor delivery
03/20/2012US8137965 Methods and compositions for tissue regeneration
03/20/2012US8137934 Regeneration and neogenesis of retinal photoreceptor cell using Otx2 gene
03/20/2012US8137925 Methods and compositions for protein labeling using lipoic acid ligases
03/20/2012US8137923 Glycoprotein VI and uses thereof
03/20/2012US8137915 Genes involved in intestinal inflammatory diseases and use thereof
03/20/2012US8137904 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
03/20/2012US8137718 Probiotic infant products
03/20/2012US8137700 Main chain acid-degradable polymers for the delivery of bioactive materials
03/20/2012US8137697 Nanoparticles for protein/peptide delivery and delivery means thereof
03/20/2012US8137696 Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
03/20/2012US8137689 Transplant/implant device and method for its production
03/20/2012US8137682 Fibronectins; inflammation
03/20/2012US8137675 Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy
03/20/2012US8137672 Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody
03/20/2012US8137666 Nattokinase for degrading and reducing amyloid fibrils—associated with alzheimer's disease, prion diseases and other amyloidoses
03/20/2012US8137661 Controlled release interferon drug products and treatment of HCV infections using same
03/20/2012CA2654610C Insulinotropic peptide synthesis
03/20/2012CA2627531C Interferon-alpha and c-phycocyanin for the treatment of autoimmune diseases, allergic diseases and cancer
03/20/2012CA2526244C Pharmaceutical combination of g-csf and plgf useful for blood stem cell mobilization
03/20/2012CA2514507C Methods and compositions for the treatment of gastrointestinal disorders
03/20/2012CA2498167C Water-soluble polymer alkanals
03/20/2012CA2489526C Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
03/20/2012CA2483547C Keratinocytes expressing exogenous angiogenic growth factors
03/20/2012CA2473513C Aggrecanase-1 and -2 peptide substrates and methods
03/20/2012CA2453300C Chimeric chains that code for proteins that induce effects directed against viruses
03/20/2012CA2446872C Immune-modulating peptide
03/20/2012CA2444463C Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
03/20/2012CA2435683C Hybridoma cell line g250 and its use for producing monoclonal antibodies
03/20/2012CA2429172C Novel mutant allergens
03/20/2012CA2410901C Methods and compounds for controlled release of recombinant parvovirus vectors
03/20/2012CA2406206C Improvements in or relating to formulations for use in inhaler devices
03/20/2012CA2405469C Integrin binding peptide derivatives
03/20/2012CA2402210C Collagen membrane carrying therapeutic genetic material for tissue regeneration
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/20/2012CA2352603C Gp120 mutants and biological applications
03/20/2012CA2299560C Human defensin def-x, gene and dnac, composition containing same and diagnostic and therapeutic applications
03/20/2012CA2296842C Ligands, including antibodies, showing reactivity against endocrine cells
03/20/2012CA2273622C Inhibition of nmda receptor signalling in reducing neuronal damage
03/20/2012CA2224320C Method of promoting hypoallergenicity or tolerogenic immune response and compositions therefor
03/15/2012WO2012034132A2 Inhibitors of human ezh2, and methods of use thereof
03/15/2012WO2012034090A1 Compositions and methods for the removal of biofilms
03/15/2012WO2012034070A1 Use of liposomal wnt compositions to enhance osseointegration
03/15/2012WO2012034068A1 Treatment of constipation-predominant irritable bowel syndrome
03/15/2012WO2012033789A2 Treatment of diseases
03/15/2012WO2012033459A1 Maturation of gastrointestinal tract
03/15/2012WO2012033450A1 Novel antimicrobial peptides
03/15/2012WO2012033427A1 Method for treating mycotic infections and drug for carrying out said method
03/15/2012WO2012033272A1 Human-derived cell-permeable peptide bioactive peptide conjugate, and use thereof
03/15/2012WO2012033016A1 Drug for treating tumor, antitumor agent, method for treating tumor and kit for treating tumor
1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 3163